One platform for all

Run patient programs and trials to generate real-world evidence and adherence.

Deliver results in a few weeks, with compliance at heart.

With experience in 30+ countries, Elfie is a true global partner to deliver impact in compliance with local clinicial, data, pharma and consumer regulation.

DIGITAL COMPANION

Engage and support patients

Elfie Digital Companion drives the industry highest level of user engagement thanks to a holistic, gamified, and world-class UI/UX.

Up to 55% retention after 1 year
All ages and countries
Any therapeutical area
4+mn medications
PATIENT PROGRAMS

Global PSP platform

ElfiePSP is a state of the art Patient Program Platform to run compliant PSPs in weeks at a fraction of the cost.

Compliant e-consent and data
Globally available
Medical impact and engagement
RWE generation
CLINICAL TRIALS

Cost-efficient decentralized and hybrid trials

ElfieResearch specialized in running trials and medical studies in markets where historically the unit economics didn’t work out.

Decentralized trials
Observational studies
Global e-consent and compliance
Participant- & investigator-first design
REAL-WORLD DATA

Anonymized data to generate market insights

ElfieData is one of the largest longitudinal database available to members of the Elfie consortium and public health agencies.

Irreversibly anonymized row-level data
Marketing insights
Medical insights (RWE)
Field force optimization
AWARENESS CAMPAIGNS

Increase awareness and adherence

Elfie conducts campaigns that drives disease awareness and medication adherence generating a measurable ROI based on sales uplift.

Go-live within two weeks globally
Real-time reporting
KOL, doctor and patient content
Medical impact and ePRO
DOCTOR PLATFORM

Engage HCPs and drive impact

ElfieCare is a unique platform that improves HCPs productivity at the benefits of their patients.

Patients management
PSP and study referrals
Secured communications
Content & education

Take a quick tour of the Elfie app

ELFIE APP

Download for free, today.